PLSE vs DXR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PLSE Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pulse Biosciences, Inc Common Stock (DE) (PLSE) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while DXR counters with relative strength in Valuation. Fundamentally, PLSE trades at N/M Forward P/E with -5861.2% operating margin (+359.3% YoY revenue) versus DXR at 64.5x Forward P/E and -5894.3% operating margin (+25.5% YoY). In options structure, PLSE sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro) against DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PLSE | DXR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.7B | $49.5M | Larger Scale | PLSE |
| Trailing P/E Ratio Valuation | N/M | 7.7x | Lower Multiple | DXR |
| Forward P/E Ratio Valuation | N/M | 64.5x | Lower Multiple | DXR |
| Revenue Growth (YoY) Growth | +359.3% | +25.5% | Higher Growth | PLSE |
| Operating Margin (TTM) Profitability | -5861.2% | -5894.3% | Higher Margin | PLSE |
| Net Profit Margin Profitability | 0.0% | 19861.4% | Higher Margin | DXR |
| Return on Equity (ROE) Capital Efficiency | -60.6% | 14.2% | Higher ROE | DXR |
| 52-Week Range Position Momentum | 73% ($13โ$59) | 2% ($8โ$15) | Stronger Trend | PLSE |
| Beta / 30D Volatility Risk Regime | 1.71ฮฒ ยท 78% Vol | 0.28ฮฒ ยท 32% Vol | Lower Realized Risk | DXR |
| Unified Institutional Score Composite Signal | 40.1 / 100 (SELL) | 52.2 / 100 (HOLD) | Higher Composite | DXR |